bioRxiv · 10.1101/641357
Global analysis of epigenetic heterogeneity identifies divergent drivers of esophageal squamous cell carcinoma
Abstract
Epigenetic landscapes can shape physiologic and disease phenotypes. We used integrative, high resolution multi-omics methods to characterize the oncogenic drivers of esophageal squamous cell carcinoma (ESCC). We found 98% of CpGs are hypomethylated across the ESCC genome and two-thirds occur in long non-coding (lnc)RNA regions. DNA methylation and epigenetic heterogeneity both coincide with chromosomal topological alterations. Gene body methylation, polycomb repressive complex occupancy, and CTCF binding sites associate with cancer-specific gene regulation. Epigenetically-mediated activation of non-canonical WNT signaling and the lncRNA ESCCAL-1 were validated as potential ESCC driver alterations. Gene-specific cancer driver roles of epigenetic alterations and heterogeneity are identified.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
CAO, W., Lee, H., Wu, W., Zaman, A., McCorkle, S., Yan, M., Chen, J., Xing, Q., Sinnott-Armstrong, N., Xu, H., Sailani, M. R., Tang, W., Cui, Y., Liu, J., Guan, H., Lv, P., Sun, X., Sun, L., Han, P., Lou, Y., Chang, J., Wang, J., Gao, Y., Guo, J., Schenk, G., Shain, A. H., Biddle, F. G., Collisson, E., Snyder, M., Bivona, T. G.. 2019-05-18. Global analysis of epigenetic heterogeneity identifies divergent drivers of esophageal squamous cell carcinoma. https://doi.org/10.1101/641357
Cite the original work for its findings. Save a collection to share your selection of sources.